| Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ... MedRxiv, 2020 | 186 | 2020 |
| A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 S Nolan, M Vignali, M Klinger, JN Dines, IM Kaplan, E Svejnoha, T Craft, ... Research square, 2020 | 155 | 2020 |
| Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies JM Sanchez‐Pina, M Rodríguez Rodriguez, N Castro Quismondo, ... European Journal of Haematology 105 (5), 597-607, 2020 | 108 | 2020 |
| High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo, A Masciulli, ... Leukemia 35 (2), 485-493, 2021 | 90 | 2021 |
| NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma A Leivas, A Valeri, L Córdoba, A García-Ortiz, A Ortiz, L Sánchez-Vega, ... Blood Cancer Journal 11 (8), 146, 2021 | 85 | 2021 |
| Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia NCP Cross, Y Hoade, WJ Tapper, G Carreno-Tarragona, T Fanelli, ... Leukemia 33 (2), 415-425, 2019 | 77 | 2019 |
| Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 T Barbui, V De Stefano, A Alvarez-Larran, A Iurlo, A Masciulli, A Carobbio, ... Blood cancer journal 11 (2), 21, 2021 | 36 | 2021 |
| Optical nanoparticles for cardiovascular imaging J Hu, DH Ortgies, E Martin Rodriguez, F Rivero, R Aguilar Torres, ... Advanced Optical Materials 6 (22), 1800626, 2018 | 31 | 2018 |
| Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse E Onecha, I Rapado, ML Morales, G Carreño-Tarragona, ... Haematologica 106 (9), 2325, 2021 | 25 | 2021 |
| Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia ML Lozano, ME Mingot-Castellano, MM Perera, I Jarque, ... Scientific Reports 9 (1), 16680, 2019 | 22 | 2019 |
| Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes A Alvarez-Larran, D Martínez, L Arenillas, A Rubio, E Arellano-Rodrigo, ... Journal of Clinical Pathology 71 (11), 975-980, 2018 | 20 | 2018 |
| Papain‐treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti‐CD38‐based therapies G Carreño‐Tarragona, T Cedena, L Montejano, R Alonso, F Miras, ... Transfusion Medicine 29 (3), 193-196, 2019 | 19 | 2019 |
| Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors M Granado, N Fernández, L Monge, JC Figueras, G Carreño-Tarragona, ... PLoS One 8 (2), e54984, 2013 | 19 | 2013 |
| Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin system M Granado, N Fernández, L Monge, G Carreño-Tarragona, JC Figueras, ... Plos one 8 (6), e65172, 2013 | 16 | 2013 |
| Long-term follow-up of recovered MPN patients with COVID-19 T Barbui, A Iurlo, A Masciulli, A Carobbio, A Ghirardi, G Rossi, C Harrison, ... Blood Cancer Journal 11 (6), 115, 2021 | 15 | 2021 |
| Second versus first wave of COVID-19 in patients with MPN T Barbui, A Iurlo, A Masciulli, A Carobbio, A Ghirardi, G Carioli, MA Sobas, ... Leukemia 36 (3), 897-900, 2022 | 14 | 2022 |
| Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea A Alvarez-Larrán, A Díaz-González, E Such, E Mora, M Andrade-Campos, ... Leukemia 35 (2), 623-627, 2021 | 14 | 2021 |
| Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to … A Alvarez‐Larrán, M Garrote, F Ferrer‐Marín, M Pérez‐Encinas, ... Cancer 128 (13), 2441-2448, 2022 | 13 | 2022 |
| Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the … A Alvarez‐Larrán, A Angona, M Andrade‐Campos, M Soledad Noya, ... British Journal of Haematology 192 (6), 988-996, 2021 | 13 | 2021 |
| Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis I Cuenca, D Alameda, B Sanchez-Vega, D Gomez-Sanchez, D Alignani, ... Leukemia 35 (1), 245-249, 2021 | 13 | 2021 |
